Mark J. Eisenberg, MD MPH FACC FAHA 5
Mark J. Eisenberg, MD MPH FACC FAHA 5
Mark J. Eisenberg, MD MPH FACC FAHA 5
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
5/1/2012<br />
23<br />
<strong>Mark</strong> J. <strong>Eisenberg</strong>, <strong>MD</strong> <strong>MPH</strong> <strong>FACC</strong> <strong>FAHA</strong><br />
91. *Goldman LE, Okrainec K, <strong>Eisenberg</strong> MJ, Schechter D, Lefkovits J, Goudreau E,<br />
Deligonul U, Mak KH, Del Core M, Duerr R, Huynh T, Smilovitch M, Sedlis S, Brown<br />
DL, Brieger D; ROSETTA Investigators. Six month outcomes after single and multilesion<br />
percutaneous coronary intervention: Results from the ROSETTA Registry. Can J<br />
Cardiol 2004; 20:608-12.<br />
92. <strong>Eisenberg</strong> MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Duerr R,<br />
Del Core M, Garzon P, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D, Pilote<br />
L. Utility of routine functional testing after percutaneous transluminal coronary<br />
angioplasty: Results from the ROSETTA Registry. J Inv Cardiol 2004; 16:318-22.<br />
93. Mak KH, <strong>Eisenberg</strong> MJ, Tsang J, Okrainec K, Huynh T, Brown D. Clinical impact of<br />
functional testing strategy among stented and non-stented patients: Insights from the<br />
ROSETTA Registry. Int J Cardiol 2004; 95:321-7.<br />
94. *Okrainec K, Banerjee DK, <strong>Eisenberg</strong> MJ. Coronary artery disease in the developing<br />
world. Am Heart J 2004; 148:7-15.<br />
95. *Jamal SM, <strong>Eisenberg</strong> MJ, Christopoulos S. Rhabdomyolysis associated with<br />
hydroxymethylglutaryl-coenzyme A reductase inhibitors. Am Heart J 2004; 147:956-65.<br />
96. Pilote L, Abrahamowicz M, Rodrigues E, <strong>Eisenberg</strong> MJ, Rahme E. Mortality rates in<br />
elderly patients who take angiotensin-converting enzyme inhibitors after acute<br />
myocardial infarction: A class effect? Ann Intern Med 2004; 141:101-12.<br />
97. Antoniou J, Martineau P, Filion KB, Haider S, Zukor D, Huk O, Pilote L, <strong>Eisenberg</strong> MJ.<br />
In-hospital costs of total hip arthroplasty in Canada and the United States. J Bone Joint<br />
Surg Am 2004; 86:2435-9.<br />
98. *Babapulle MN, Joseph L, Bélisle P, Brophy JM, <strong>Eisenberg</strong> MJ. A hierarchical<br />
Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004;<br />
364:583-91.<br />
99. <strong>Eisenberg</strong> MJ. Drug-eluting stents: Some bare facts. Lancet 2004; 364:1466-7.<br />
100. *Okrainec K, Platt R, Pilote L, <strong>Eisenberg</strong> MJ. Cardiac medical therapy in patients<br />
undergoing coronary artery bypass graft surgery: A review of randomized controlled<br />
trials. J Am Coll Cardiol 2005; 45:177-84.<br />
101. *Saririan M, Cugno S, Blankenship J, Huynh T, Pilote L, Wilson B, <strong>Eisenberg</strong> MJ.<br />
Routine versus selective functional testing after percutaneous coronary intervention in<br />
patients with diabetes mellitus. J Inv Cardiol 2005; 17:25-9.<br />
102. *Gioia LC, Filion KB, Haider S, Pilote L, <strong>Eisenberg</strong> MJ. Hospital readmissions<br />
following abdominal aortic aneurysm repair. Ann Vasc Surg 2005; 19:35-41.<br />
103. *Buresly K, <strong>Eisenberg</strong> MJ, Zhang X, Pilote L. Bleeding complications associated with<br />
combinations of aspirin, thienopyridine derivatives and warfarin in elderly patients<br />
following acute myocardial infarction. Arch Intern Med 2005; 165:784-9.